|
US6849708B1
(en)
|
1986-05-05 |
2005-02-01 |
The General Hospital Corporation |
Insulinotropic hormone and uses thereof
|
|
US7138486B2
(en)
|
1986-05-05 |
2006-11-21 |
The General Hospital Corporation |
Insulinotropic hormone derivatives and uses thereof
|
|
US5614492A
(en)
*
|
1986-05-05 |
1997-03-25 |
The General Hospital Corporation |
Insulinotropic hormone GLP-1 (7-36) and uses thereof
|
|
FR2686899B1
(fr)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
|
US6284727B1
(en)
|
1993-04-07 |
2001-09-04 |
Scios, Inc. |
Prolonged delivery of peptides
|
|
EP1826216A1
(en)
*
|
1996-08-30 |
2007-08-29 |
Novo Nordisk A/S |
Glp-1 derivatives
|
|
US6461834B1
(en)
|
1998-11-06 |
2002-10-08 |
Bionebraska, Inc. |
Clostripain catalyzed amidation of peptides
|
|
WO2001079480A1
(en)
|
2000-04-12 |
2001-10-25 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
CN1162446C
(zh)
*
|
2001-05-10 |
2004-08-18 |
上海华谊生物技术有限公司 |
促胰岛素分泌肽衍生物
|
|
CN1363654A
(zh)
*
|
2001-07-19 |
2002-08-14 |
上海华谊生物技术有限公司 |
生产促胰岛素分泌肽glp－1(7－36)的基因工程菌以及生产glp－1(7－36)的方法
|
|
ES2545090T3
(es)
|
2001-12-21 |
2015-09-08 |
Human Genome Sciences, Inc. |
Proteínas de fusión de albúmina y GCSF
|
|
WO2003099848A2
(en)
|
2002-05-24 |
2003-12-04 |
Restoragen Inc. |
Method for universal enzymatic production of bioactive peptides
|
|
WO2003099847A2
(en)
*
|
2002-05-24 |
2003-12-04 |
Restoragen, Inc. |
Method for enzymatic production of glp-1 (7-36) amide peptides
|
|
WO2003099854A2
(en)
|
2002-05-24 |
2003-12-04 |
Nps Allelix Corp. |
Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
|
|
EP1594530A4
(en)
|
2003-01-22 |
2006-10-11 |
Human Genome Sciences Inc |
HYBRID PROTEINS OF ALBUMIN
|
|
WO2005067368A2
(en)
|
2003-11-21 |
2005-07-28 |
Nps Allelix Corp. |
Production of glucagon like peptide 2 and analogs
|
|
HUE027902T2
(en)
*
|
2004-02-09 |
2016-11-28 |
Human Genome Sciences Inc Corp Service Company |
Albumin fusion proteins
|
|
CN100429227C
(zh)
|
2005-06-29 |
2008-10-29 |
常州制药厂有限公司 |
Exendin4多肽片段
|
|
EP1816201A1
(en)
|
2006-02-06 |
2007-08-08 |
CSL Behring GmbH |
Modified coagulation factor VIIa with extended half-life
|
|
WO2016210384A2
(en)
|
2015-06-25 |
2016-12-29 |
Synlogic, Inc. |
Bacteria engineered to treat metabolic diseases
|
|
WO2017139708A1
(en)
|
2016-02-10 |
2017-08-17 |
Synlogic, Inc. |
Bacteria engineered to treat nonalcoholic steatohepatitis (nash)
|
|
AU2018238302A1
(en)
|
2017-03-20 |
2019-10-24 |
Lupin Limited |
Expression and large-scale production of peptides
|
|
CN113846124A
(zh)
*
|
2021-09-26 |
2021-12-28 |
康霖生物科技（杭州）有限公司 |
一种用于糖代谢相关疾病基因治疗的核酸构建体
|